| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00417-016-3473-0 |
| P698 | PubMed publication ID | 27553051 |
| P50 | author | Alex Ng | Q85491016 |
| P2093 | author name string | Kenneth Kai-Wang Li | |
| Patrick Siu-Hung Li | |||
| Wilson Wai-Tat Tang | |||
| P2860 | cites work | Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors | Q28304030 |
| Antibiotic prevention of postcataract endophthalmitis: a systematic review and meta-analysis. | Q35579070 | ||
| Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment | Q36161606 | ||
| Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries | Q38132483 | ||
| Adherence to European Society for Cataract and Refractive Surgery recommendations among Italian cataract surgeons: a survey | Q40003975 | ||
| Surgical, antiseptic, and antibiotic practice in cataract surgery: Results from the European Observatory in 2013. | Q40077009 | ||
| Endophthalmitis Occurring after Cataract Surgery: Outcomes of More Than 480 000 Cataract Surgeries, Epidemiologic Features, and Risk Factors. | Q40170933 | ||
| Efficacy of Intracameral Moxifloxacin Endophthalmitis Prophylaxis at Aravind Eye Hospital | Q40368945 | ||
| Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: Results of the 2014 ASCRS member survey | Q40720748 | ||
| Comparative Effectiveness of Antibiotic Prophylaxis in Cataract Surgery | Q40955855 | ||
| Intracameral cefuroxime and the incidence of post-cataract endophthalmitis: an Israeli experience | Q41026130 | ||
| Transient macular edema after intracameral injection of a moderately elevated dose of cefuroxime during phacoemulsification surgery | Q41475096 | ||
| Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India | Q41585065 | ||
| Assessing the accuracy of intracameral antibiotic preparation for use in cataract surgery | Q43163625 | ||
| Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery Ten-year comparative study | Q43163631 | ||
| Cataract surgery practices and endophthalmitis prophylaxis by New Zealand Ophthalmologists | Q43449681 | ||
| Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study. | Q43716858 | ||
| Six-year incidence of endophthalmitis after cataract surgery: Swedish national study | Q44324114 | ||
| Anaphylactic reaction following intracameral cefuroxime injection during cataract surgery | Q44473115 | ||
| Intracameral Antibiotics Reduce the Risk of Endophthalmitis after Cataract Surgery: Does the Preponderance of the Evidence Mandate a Global Change in Practice? | Q45025943 | ||
| United Kingdom survey of antibiotic prophylaxis practice after publication of the ESCRS Endophthalmitis Study | Q45366236 | ||
| Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department | Q46072387 | ||
| Prophylactic intracameral cefazolin after cataract surgery: endophthalmitis risk reduction and safety results in a 6-year study | Q46079561 | ||
| Severe anaphylactic reaction after intracameral antibiotic administration during cataract surgery | Q46423398 | ||
| Incidence of endophthalmitis and impact of prophylaxis with cefuroxime on cataract surgery | Q46920854 | ||
| Toxic anterior segment syndrome: Update on the most common causes. | Q50909667 | ||
| Ocular toxicity after intracameral injection of very high doses of cefuroxime during cataract surgery. | Q51732610 | ||
| Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study | Q71863618 | ||
| Epidemiology of postoperative endophthalmitis in an Asian population: 11-year incidence and effect of intracameral antibiotic agents | Q83242774 | ||
| Ocular toxicity in cataract surgery because of inaccurate preparation and erroneous use of 50mg/ml intracameral cefuroxime | Q83796285 | ||
| Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: update on the ESCRS Endophthalmitis Study | Q86981326 | ||
| Tolerability of intracameral cefuroxime during cataract surgery in case of penicillin allergy | Q87051885 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1987-1992 | |
| P577 | publication date | 2016-08-24 | |
| P1433 | published in | Graefe's Archive for Clinical and Experimental Ophthalmology | Q15757667 |
| P1476 | title | Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong | |
| P478 | volume | 254 |
| Q87992716 | Author's reply: Re: Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong |
| Q88053809 | Intracameral cefuroxime in the prevention of postoperative endophthalmitis |
| Q50045480 | Phacoemulsification cataract surgery in patients receiving novel oral anticoagulant medications |
| Q33691967 | Risks of Cefuroxime Prophylaxis for Postcataract Endophthalmitis |
| Q89425491 | The Routine Use of Intracameral Antibiotics to Prevent Endophthalmitis After Cataract Surgery: How Good is the Evidence? |
Search more.